Search by Drug Name or NDC
NDC 55292-0122-52 NEOPROFEN 10 mg/mL Details
NEOPROFEN 10 mg/mL
NEOPROFEN is a INTRAVENOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Recordati Rare Diseases Inc.. The primary component is IBUPROFEN LYSINE.
Product Information
| NDC | 55292-0122 |
|---|---|
| Product ID | 55292-122_8893e663-d79a-498d-9429-beb94b98a9fa |
| Associated GPIs | 66100020402010 |
| GCN Sequence Number | 060994 |
| GCN Sequence Number Description | ibuprofen lysine/PF VIAL 20 MG/2 ML INTRAVEN |
| HIC3 | A5A |
| HIC3 Description | PATENT DUCTUS ARTERIOSUS TREAT. AGENTS, NSAID-TYPE |
| GCN | 27148 |
| HICL Sequence Number | 033810 |
| HICL Sequence Number Description | IBUPROFEN LYSINE/PF |
| Brand/Generic | Brand |
| Proprietary Name | NEOPROFEN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ibuprofen lysine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | IBUPROFEN LYSINE |
| Labeler Name | Recordati Rare Diseases Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021903 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55292-0122-52 (55292012252)
| NDC Package Code | 55292-122-52 |
|---|---|
| Billing NDC | 55292012252 |
| Package | 3 VIAL in 1 CARTON (55292-122-52) / 2 mL in 1 VIAL |
| Marketing Start Date | 2006-04-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |